Popular hospital disinfectants ineffective against common superbugs
- Early Biomarker for Multiple Sclerosis Development Identified Years in Advance
- Aspirin Found Ineffective in Improving Recurrence Risk or Survival Rate of Breast Cancer Patients
- Child Products from Aliexpess and Temu Contain Carcinogens 3026x Over Limit
- Daiichi Sankyo/AstraZeneca’s Enhertu Shows Positive Results in Phase III DESTINY-Breast06 Clinical Trial
- Mn007 Molecules Offer Potential for Combating Streptococcus pyogenes Infection
- Popular Indian Spices Banned in Hong Kong Over Carcinogen Concerns
Popular hospital disinfectants ineffective against common superbugs
- AstraZeneca Admits for the First Time that its COVID Vaccine Has Blood Clot Side Effects
- Was COVID virus leaked from the Chinese WIV lab?
- HIV Cure Research: New Study Links Viral DNA Levels to Spontaneous Control
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Popular hospital disinfectants ineffective against common superbugs
A new study has found that hospital disinfectants, including high concentrations of bleach, are ineffective against Clostridium difficile spores, a major cause of antibiotic-related diseases.
This discovery highlights the urgency of adopting new disinfection methods, as the impact of antibiotic resistance and Clostridium difficile infections is increasingly gaining attention worldwide.
Research conducted during the World Antibiotic Awareness Week explored the effectiveness of chlorine-based chemicals recommended to combat Clostridium difficile, a leading cause of antibiotic-related diseases in global healthcare environments.
The latest study reveals that a major chlorine disinfectant used in hospitals fails to eliminate the primary cause of antibiotic-related diseases in global healthcare environments. This finding comes from research conducted at the University of Plymouth.
The study examined the spore reactions of three different strains to three clinical concentrations of sodium hypochlorite. Spores were then added to surgical and patient gowns, and examined using scanning electron microscopy to determine if there were any morphological changes in the spore coats.
The research indicates that despite many hospitals using high concentrations of bleach for treatment, Clostridium difficile spores, also known as C. difficile, remain entirely unaffected. In fact, chlorine-based chemicals used as surface disinfectants are no more effective at destroying spores than using water without additives.
The authors of the study, writing in the journal “Microbiology,” suggest that individuals working and undergoing treatment in clinical environments may unknowingly face the risk of infection from this superbug.
As the overuse of biocides contributes to the rise of global antimicrobial resistance (AMR), the researchers call for urgent studies to find alternative methods to disinfect Clostridium difficile spores and break the transmission chain in clinical environments.
Dr. Tina Joshi, Associate Professor of Molecular Microbiology at the University of Plymouth, and fourth-year medical student Humaira Ahmed, jointly conducted this research.
Dr. Joshi stated, “With the increasing incidence of antimicrobial resistance, the threat of superbugs to human health is also on the rise. However, this study not only fails to prove that our clinical environments are clean and safe for staff and patients, but it emphasizes the ability of C. difficile spores to tolerate disinfection at recommended active chlorine concentrations. It suggests that we need disinfectants and guidelines that are fit for purpose and align with the evolution of bacteria, and this study should have significant implications for current disinfection protocols in the global healthcare sector.”
Clostridium difficile is a microorganism that can cause diarrhea, colitis, and other intestinal complications, infecting millions globally each year. It results in approximately 29,000 deaths in the United States and nearly 8,500 deaths in Europe annually. Recent data indicates an increasing incidence of Clostridium difficile infections in the UK before the onset of the COVID-19 pandemic.
Dr. Joshi and colleagues had previously demonstrated the survival of Clostridium difficile spores when exposed to recommended concentrations of liquid sodium dichloroisocyanurate and personal protective fabrics, such as surgical gowns.
Dr. Joshi, a member of the Microbiology Society Council and Co-Chair of the Impact and Influence Committee, added, “Understanding how these spores interact with disinfectants is crucial for effectively managing Clostridium difficile infections and reducing the burden of infections in healthcare institutions. However, there are still unanswered questions about the tolerance of Clostridium difficile to disinfectants and whether it will be influenced by antibiotic co-resistance. With the continuous increase of AMR globally, it is now more urgent than ever to find answers to these questions, whether for Clostridium difficile or other superbugs.”
What is antibiotic resistance?
Popular hospital disinfectants ineffective against common superbugs
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.